Cargando…

Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen

BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Babel, Ingrid, Barderas, Rodrigo, Peláez-García, Alberto, Casal, J Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125328/
https://www.ncbi.nlm.nih.gov/pubmed/21635725
http://dx.doi.org/10.1186/1472-6750-11-61
_version_ 1782207208008712192
author Babel, Ingrid
Barderas, Rodrigo
Peláez-García, Alberto
Casal, J Ignacio
author_facet Babel, Ingrid
Barderas, Rodrigo
Peláez-García, Alberto
Casal, J Ignacio
author_sort Babel, Ingrid
collection PubMed
description BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we describe a novel methodology to select human monoclonal recombinant antibodies by combining in vitro protein expression, phage display antibody libraries and antibody microarrays. The application of this combination of methodologies permitted us to generate human single-chain variable fragments (scFvs) against two proteins: green fluorescent protein (GFP) and thioredoxin (Trx) in a short time, using as low as 5 μg of purified protein. These scFvs showed specific reactivity against their respective targets and worked well by ELISA and western blot. The scFvs were able to recognise as low as 31 ng of protein of their respective targets by western blot. CONCLUSION: This work describes a novel and miniaturized methodology to obtain human monoclonal recombinant antibodies against any target in a shorter time than other methodologies using only 5 μg of protein. The protocol could be easily adapted to a high-throughput procedure for antibody production.
format Online
Article
Text
id pubmed-3125328
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31253282011-06-29 Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen Babel, Ingrid Barderas, Rodrigo Peláez-García, Alberto Casal, J Ignacio BMC Biotechnol Research Article BACKGROUND: Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. RESULTS: Here, we describe a novel methodology to select human monoclonal recombinant antibodies by combining in vitro protein expression, phage display antibody libraries and antibody microarrays. The application of this combination of methodologies permitted us to generate human single-chain variable fragments (scFvs) against two proteins: green fluorescent protein (GFP) and thioredoxin (Trx) in a short time, using as low as 5 μg of purified protein. These scFvs showed specific reactivity against their respective targets and worked well by ELISA and western blot. The scFvs were able to recognise as low as 31 ng of protein of their respective targets by western blot. CONCLUSION: This work describes a novel and miniaturized methodology to obtain human monoclonal recombinant antibodies against any target in a shorter time than other methodologies using only 5 μg of protein. The protocol could be easily adapted to a high-throughput procedure for antibody production. BioMed Central 2011-06-02 /pmc/articles/PMC3125328/ /pubmed/21635725 http://dx.doi.org/10.1186/1472-6750-11-61 Text en Copyright ©2011 Babel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Babel, Ingrid
Barderas, Rodrigo
Peláez-García, Alberto
Casal, J Ignacio
Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title_full Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title_fullStr Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title_full_unstemmed Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title_short Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen
title_sort antibodies on demand: a fast method for the production of human scfvs with minimal amounts of antigen
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125328/
https://www.ncbi.nlm.nih.gov/pubmed/21635725
http://dx.doi.org/10.1186/1472-6750-11-61
work_keys_str_mv AT babelingrid antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen
AT barderasrodrigo antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen
AT pelaezgarciaalberto antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen
AT casaljignacio antibodiesondemandafastmethodfortheproductionofhumanscfvswithminimalamountsofantigen